QRG Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.18M	Buy	16,519 +305	+2%	+$40.5K	0.02%	406
2025 Q4	$2.3M	Sell	16,214 -3,217	-17%	-$466K	0.03%	387
2025 Q3	$2.73M	Sell	19,431 -3,150	-14%	-$427K	0.03%	330
2025 Q2	$2.84M	Buy	22,581 +2,519	+13%	+$289K	0.02%	412
2025 Q1	$2.22M	Buy	20,062 +1,330	+7%	+$168K	0.02%	437
2024 Q4	$2.56M	Buy	18,732 +453	+2%	+$56K	0.03%	412
2024 Q3	$2.11M	Buy	18,279 +569	+3%	+$78K	0.02%	433
2024 Q2	$2.44M	Buy	17,710 +1,832	+12%	+$251K	0.03%	380
2024 Q1	$2.19M	Buy	15,878 +1,352	+9%	+$185K	0.03%	399
2023 Q4	$1.91M	Buy	14,526 +1,685	+13%	+$194K	0.03%	407
2023 Q3	$1.44M	Buy	+12,841	New	+$1.35M	0.03%	428